Seeing the Future of Lung Cancer Vaccination.

The article discusses the advancements in lung cancer vaccination, highlighting the challenges faced in targeting this disease effectively. It mentions the development of personalized vaccines targeting neoantigens and the use of mRNA technology, such as the BNT116 vaccine, to treat non-small-cell lung cancer. The article also explores the potential of combining vaccines with existing immunotherapies to enhance the immune system's ability to combat cancer cells. Ongoing research aims to reshape the future of lung cancer vaccination, offering hope for improved treatments and potential preventive vaccines in the future. [Extracted from the article]